mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.0086 |
0.8 |